Editor Brian Harrod Provides Comprehensive up-to-date news coverage, with aggregated news from sources all over the world from the Roundup Newswires Network
A report released by Missouri Sen. Claire McCaskill points to $10 million of payments flowing from a group of five opioid-producing companies to 15 patient advocacy groups over a five-year period. The hundreds of pending opioid abuse lawsuits likely have just received a jolt from a report from the Senate Committee on Homeland Security and Governmental Affairs linking opioid manufacturers and patient advocacy groups.
FILE PHOTO: The billionaire founder of Insys Therapeutics Inc. John Kapoor, exits the federal court house after a bail hearing in Phoenix, Arizona , U.S., October 27, 2017. REUTERS/Conor Ralph Insys's billionaire founder John Kapoor was arrested on charges that he participated in a scheme to bribe doctors to prescribe Subsys.
Amritsar-born entrepreneur John Nath Kapoor was arrested by the FBI for bribing doctors to over-prescribe a powerful opioid to patients. A 74-year-old Indian-American pharmaceutical billionaire was on Friday charged with leading a nationwide conspiracy in the US by bribing doctors to over-prescribe a powerful opioid to patients and committing fraud on insurance firms for profit.
U.S. prosecutors leveled charges Thursday against the billionaire founder of an opioid medication maker that has faced increasing scrutiny from authorities across the country over allegations of pushing prescriptions of powerful painkillers amid a drug epidemic that is claiming thousands of lives each year. The fraud and racketeering case against Insys Therapeutics founder John Kapoor, ... U.S. prosecutors leveled charges Thursday against the billionaire founder of an opioid medication maker that has faced increasing scrutiny from authorities across the country over allegations of pushing prescriptions of powerful painkillers amid a drug epidemic that is claiming thousands of lives each year.
John Kapoor, a billionaire whose company developed a liquid version of the opioid painkiller fentanyl, was arrested in Phoenix on Thursday on charges that he spearheaded a scheme to bribe doctors and pharmacists across the nation to boost sales - largely to patients who did not need the medication. The scheme was first described in December in an indictment against six executives at the company, Insys Therapeutics in Chandler, Ariz.
Ongoing investigations into the marketing of its once high-flying fentanyl spray, Subsys, have taken a lot of the luster off Insys Therapeutics ' attempt to reshape marijuana's use as medicine. Today, investigations by the Justice Department led to the arrest of former Insys Therapeutics employees, including former CEO Michael Babich, casting more uncertainty on this company's future.